On November 8th, our Austrian team introduced Prolaris at ÖGU 2024. Prolaris is designed to assess prostate cancer aggressiveness, giving patients and healthcare providers the information they need for tailored, informed treatment choices.

Thanks to our Stephanie Örtel, Gerald Gölzner and Nadine Schinko for their dedication in bringing this advancement to the Austrian medical community.

#ProstateCancer  #PrecisionMedicine  #Prolaris  #ÖGU2024  #TeamAustria  #HealthcareInnovation